| Chase Michael Hunter, | |
|
3510 Se 14th St, Bentonville, AR 72712-4931 | |
| (479) 621-6470 | |
| (479) 621-6461 |
| Full Name | Chase Michael Hunter |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3510 Se 14th St, Bentonville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700486206 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | PD13196 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Chase Michael Hunter, 1718 N Desarc Way, Fayetteville, AR 72704-6904 Ph: (479) 883-4723 | Chase Michael Hunter, 3510 Se 14th St, Bentonville, AR 72712-4931 Ph: (479) 621-6470 |
News Archive
Parks played an important role for people seeking respite from the toll of social isolation during the pandemic, and according to new research from Drexel University, they did so without increasing the spread of COVID-19.
In an effort to address emergency department overcrowding, pay-for-performance (P4P) incentive programs have been implemented in various regions around the world, including hospitals in Metro Vancouver.
One of the primary tools that oncologists use to stage cancers is the PET (positron emission tomography) scan, an imaging test that uses a small amount of radioactive sugar to detect metabolically active areas within the body.
Heart failure patients who are treated in accordance with established European guidelines do better than patients who are not, yet many doctors are still not adhering to the guidelines, according to pioneering research published in Europe's leading cardiology journal, the European Heart Journal.
AEterna Zentaris Inc., a global biopharmaceutical company focused on endocrine therapy and oncology, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the Company's PI3K/Akt pathway inhibitor compound, perifosine (KRX-0401), for the treatment of relapsed/refractory multiple myeloma.
› Verified 4 days ago
Michael Fertig, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2730 Sw Livingston Sq, Bentonville, AR 72713 Phone: 214-578-3685 | |
Jessie Joann Kruse, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1204 Se 28th St Ste 2, Bentonville, AR 72712 Phone: 888-414-5805 Fax: 855-422-2400 | |
Darren Keith Townzen, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 702 Sw 8th St, Bentonville, AR 72712 Phone: 479-381-6136 | |
Rane Dearing, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Se 14th St, Bentonville, AR 72712 Phone: 479-621-6470 Fax: 479-621-6461 | |
Pierce Wyland Skersick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2805 Mid Cities Dr, Bentonville, AR 72712 Phone: 479-271-7634 | |
Tatum Bishop, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3510 Se 14th St, Bentonville, AR 72712 Phone: 479-621-9470 | |
Mr. Kirk Eugene Milam, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 316 Nw Lasalle Dr, Bentonville, AR 72712 Phone: 479-271-9007 |